Neuromodulation (neurostimulation) is a relatively new and rapidly growing treatment for
refractory epilepsy. Three varieties are approved in the US: vagus nerve stimulation (VNS) …

It is a major challenge in clinical epilepsy to diagnose and treat a disease characterized by
infrequent seizures based on patient or caregiver reports and limited duration clinical …

Neural recordings using invasive devices in humans can elucidate the circuits underlying
brain disorders, but have so far been limited to short recordings from externalized brain …

Objectives To review clinical evidence on the antiepileptic effects of deep brain stimulation
(DBS) for drug‐resistant epilepsy, its safety, and the factors influencing individual outcomes …

Introduction: Deep brain stimulation is a safe and effective neurointerventional technique for
the treatment of movement disorders. Electrical stimulation of subcortical structures may …

Rapid advancements in neurostimulation technologies are providing relief to an
unprecedented number of patients affected by debilitating neurologic and psychiatric …

Epilepsy is a unique neurologic condition characterized by recurrent seizures, where
causes, underlying biomarkers, triggers, and patterns differ across individuals. The …

Deep brain stimulation and responsive neurostimulation (RNS) use high‐frequency
stimulation (HFS) per the pivotal trials and manufacturer‐recommended therapy protocols …

OBJECTIVE Dysfunction of distributed neural networks underlies many brain disorders. The
development of neuromodulation therapies depends on a better understanding of these …

OBJECTIVE Deep brain stimulation (DBS) of the anterior nucleus of the thalamus (ANT) is a
promising therapy for refractory epilepsy. Unfortunately, the variability in outcomes from ANT …